# Amylyx Pharmaceuticals, Inc. (AMLX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/amlx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.

## Quote & Key Metrics

As of 2026-10-27:

| Metric | Value |
|---|---|
| Price | $27.62 USD |
| Market Cap | $3.47B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.43 |
| 52-Week Range | $10.83 – $41.14 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | — / — / — / — |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2018-03-28 | $0.4200 | 2018-04-02 |
| 2017-12-28 | $0.3600 | 2018-01-02 |
| 2017-09-28 | $0.2400 | 2017-10-02 |

Full history: https://www.dividenddata.com/stocks/amlx/dividend

## Frequently Asked Questions

### What does Amylyx Pharmaceuticals, Inc. do?

Amylyx Pharmaceuticals, Inc. (AMLX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is AMLX's market cap?

Amylyx Pharmaceuticals, Inc. (AMLX) has a market capitalization of approximately $3.47 billion, as of October 27, 2026, based on the most recent share price and shares outstanding.

### Does AMLX pay a dividend?

No, Amylyx Pharmaceuticals, Inc. (AMLX) is not currently paying a dividend. Its last ex-dividend date was March 28, 2018 ($0.42 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### Is AMLX profitable?

Amylyx Pharmaceuticals, Inc. (AMLX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### How often did AMLX pay dividends?

Amylyx Pharmaceuticals, Inc. paid dividends quarterly until 2018; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is AMLX's payout ratio?

Amylyx Pharmaceuticals, Inc.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/amlx
- Dividend history & safety: https://www.dividenddata.com/stocks/amlx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/amlx/earnings
- Financial statements: https://www.dividenddata.com/stocks/amlx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/amlx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/amlx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.